Induced pluripotent stem cell therapy for degenerated IVD
诱导多能干细胞治疗退化性 IVD
基本信息
- 批准号:10388144
- 负责人:
- 金额:$ 11.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAnimal ModelAntiinflammatory EffectAreaAttenuatedBack PainBiologyBone TissueCartilageCell SurvivalCell TherapyCellsChildChronicCicatrixDataDevelopmentDiseaseDyesEducational workshopEmbryonic DevelopmentEnvironmentFamily suidaeFibrosisFundingGene DeliveryGene ExpressionGene Expression ProfilingGeneticGoalsHarvestHistologicHumanIL8 geneImageImaging technologyImmunoassayImmunologyInflammationInflammatoryInjectionsInjuryInstitute of Medicine (U.S.)Interferon Type IIInterleukin-1 betaInterleukin-17Interleukin-6Intervertebral disc structureKnowledgeLabelLeadershipLinkMagnetic Resonance ImagingMeasuresMentored Research Scientist Development AwardMentorsMentorshipMethodsModelingMolecular BiologyMonitorMusculoskeletalNatural regenerationNeedlesOrgan Culture TechniquesOutcome StudyPainParentsPathogenesisPatientsPeptidesPhenotypePhysiologicalPlayPopulationPositioning AttributeProcessProteinsPublicationsPuncture procedureQuantitative Reverse Transcriptase PCRRegenerative MedicineRejuvenationReportingResearchResearch PersonnelRoleSeasonsSolidSourceSupervisionSymptomsTNF geneTechniquesTestingTherapeuticTherapeutic EffectTissue EngineeringTrainingTraining ProgramsVertebral columnVisitage relatedalternative treatmentbasecareercell typecytokinedesigndisc regenerationexperiencehands on researchimmunoregulationimprovedin vivoin vivo Modelinduced pluripotent stem cellinnovationintervertebral disk degenerationnotochordnovelnucleus pulposuspreclinical studyquantitative imagingregeneration potentialsoft tissuestem cell therapystem cellstargeted treatmenttissue regenerationtranscriptome sequencing
项目摘要
Project Summary/abstract
As many as 80% of the adult population experience back pain at some point in their lifetimes. Previous studies
have indicated a link between back pain and intervertebral disc (IVD) degeneration in 40% of patients. Despite
decades of research, robust therapies targeting underlying causes rather than symptoms are still in the earliest
stages of development. Thus, there is an urgent need for alternative treatment, such as stem cell therapy,
focused on correcting the underlying pathogenesis of DDD. Dr. Sheyn’s goal is to develop his academic career
in musculoskeletal tissue engineering and stem cell therapy field, focusing on spine therapeutics. He has
received excellent training in stem cell manipulation and gene delivery, in vivo models, bone tissue engineering
and molecular biology. He has established solid track record of publications in the field and demonstrated
strong capacity to conduct innovative research. The proposed training program is designed to build on Dr.
Sheyn’s background and strengthen his expertise in specific areas most relevant to IVD therapeutics. Under
the leadership and sponsorship of Dr. Clive Svendsen, the director of the Cedars-Sinai Regenerative Medicine
Institute, Dr. Sheyn will gain experience in the three research areas: 1) development of soft tissue and cartilage
biology; 2) immunology and inflammation; 3) quantitative imaging of soft tissue using magnetic resonance
imaging (MRI). We will utilize formal workshops and courses and hands-on research supervised by seasoned
mentors with extensive track record in these areas and mentorship to achieve those training goals. In the
proposed study we will study the link between the possible mechanism of disc degeneration and the potential
cell therapy. Firstly, we will investigate the developmental phenotype of novel induced pluripotent stem cell-
derived notochordal cells as a potential source of cells to reverse the degeneration process and fibrosis of the
disc. This aim will be conducted under mentorship of Dr. Lyons, well-established developmental and
musculoskeletal biologist from UCLA and Dr. Hoyland, world expert in the notochord and IVD biology from
Manchester U, UK. Secondly we will use the annular injury model of disc degeneration in pigs to study the role
of pro-inflammatory and catabolic cytokines expressed by the NP cells under mentorship of Dr. Arditi, world
known expert in immunology, inflammation and fibrosis., In Aim 3, the IVD degeneration will be assessed using
MRI as shown in preliminary results, but also we will monitor the regeneration of the IVD using iPS-derived
notochordal-like cells will be monitored under supervision of Dr. Li, world leader in MR research and imaging.
Overall this study will improve our understanding of the disc degeneration and possible regeneration
strategies, as well as will serve as excellent vehicle for Dr. Sheyn to strengthen his expertise in areas critical
for addressing the DDD therapy and will place him in strong position to establish independent research to
compete for substantial funding (R01).
项目概要/摘要
多达 80% 的成年人在一生中的某个时刻经历过背痛。之前的研究
表明 40% 的患者背痛与椎间盘 (IVD) 退变之间存在联系。尽管
经过数十年的研究,针对根本原因而不是症状的强有力的治疗方法仍处于最早阶段
发展阶段。因此,迫切需要替代治疗,例如干细胞疗法,
专注于纠正 DDD 的潜在发病机制。 Sheyn 博士的目标是发展他的学术生涯
在肌肉骨骼组织工程和干细胞治疗领域,专注于脊柱治疗。他有
在干细胞操作和基因传递、体内模型、骨组织工程方面接受过良好的培训
和分子生物学。他在该领域的出版物中建立了良好的记录,并证明了
较强的创新研究能力。拟议的培训计划旨在以博士为基础。
Sheyn 的背景并增强了他在与 IVD 治疗最相关的特定领域的专业知识。在下面
Cedars-Sinai 再生医学中心主任 Clive Svendsen 博士的领导和赞助
Sheyn博士将在研究所获得三个研究领域的经验:1)软组织和软骨的发育
生物学; 2)免疫学和炎症; 3)利用磁共振对软组织进行定量成像
成像(MRI)。我们将利用正式的研讨会和课程以及由经验丰富的人监督的实践研究
在这些领域拥有丰富记录的导师以及实现这些培训目标的指导。在
拟议的研究我们将研究椎间盘退变的可能机制和潜在的之间的联系
细胞疗法。首先,我们将研究新型诱导多能干细胞的发育表型-
衍生的脊索细胞作为逆转脊索退化过程和纤维化的潜在细胞来源
光盘。这一目标将在 Lyons 博士的指导下进行,他拥有完善的发展和
加州大学洛杉矶分校 (UCLA) 的肌肉骨骼生物学家和脊索和 IVD 生物学世界专家 Hoyland 博士
英国曼彻斯特大学。其次我们将利用猪椎间盘退变的环状损伤模型来研究其作用
在 Arditi 博士的指导下,世界各地的 NP 细胞表达促炎和分解代谢细胞因子
免疫学、炎症和纤维化领域的知名专家。在目标 3 中,将使用以下方法评估 IVD 退化
初步结果显示 MRI,但我们也将使用 iPS 衍生来监测 IVD 的再生
脊索样细胞将在核磁共振研究和成像领域的世界领导者李博士的监督下进行监测。
总的来说,这项研究将提高我们对椎间盘退变和可能的再生的理解
战略,并将成为 Sheyn 博士加强关键领域专业知识的绝佳工具
致力于解决 DDD 疗法,并将使他处于有利地位来建立独立研究
竞争大量资金(R01)。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Electrospun, synthetic bone void filler promotes human MSC function and BMP-2 mediated spinal fusion.
- DOI:10.1177/0885328220937999
- 发表时间:2020-10
- 期刊:
- 影响因子:2.9
- 作者:Glaeser JD;Salehi K;Kanim LE;Ju DG;Hyuk Yang J;Behrens PH;Eberlein SA;Metzger MF;Arabi Y;Stefanovic T;Sheyn D;W Bae H
- 通讯作者:W Bae H
Single-cell atlas unveils cellular heterogeneity and novel markers in human neonatal and adult intervertebral discs.
单细胞图谱揭示了人类新生儿和成人椎间盘的细胞异质性和新标记。
- DOI:10.1016/j.isci.2022.104504
- 发表时间:2022-07-15
- 期刊:
- 影响因子:5.8
- 作者:Jiang W;Glaeser JD;Salehi K;Kaneda G;Mathkar P;Wagner A;Ho R;Sheyn D
- 通讯作者:Sheyn D
Assessing the Resident Progenitor Cell Population and the Vascularity of the Adult Human Meniscus.
- DOI:10.1016/j.arthro.2020.09.021
- 发表时间:2021-01
- 期刊:
- 影响因子:0
- 作者:Chahla J;Papalamprou A;Chan V;Arabi Y;Salehi K;Nelson TJ;Limpisvasti O;Mandelbaum BR;Tawackoli W;Metzger MF;Sheyn D
- 通讯作者:Sheyn D
Molecular pain markers correlate with pH-sensitive MRI signal in a pig model of disc degeneration.
- DOI:10.1038/s41598-018-34582-6
- 发表时间:2018-11-26
- 期刊:
- 影响因子:4.6
- 作者:Bez M;Zhou Z;Sheyn D;Tawackoli W;Giaconi JC;Shapiro G;Ben David S;Gazit Z;Pelled G;Li D;Gazit D
- 通讯作者:Gazit D
Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites.
- DOI:10.3390/bioengineering10091049
- 发表时间:2023-09-06
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dmitriy Sheyn其他文献
Dmitriy Sheyn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dmitriy Sheyn', 18)}}的其他基金
Stem cell-loaded microgels to treat discogenic low back pain
装载干细胞的微凝胶可治疗椎间盘源性腰痛
- 批准号:
10398627 - 财政年份:2021
- 资助金额:
$ 11.92万 - 项目类别:
Induced pluripotent stem cell therapy for degenerated IVD
诱导多能干细胞治疗退化性 IVD
- 批准号:
9891953 - 财政年份:2018
- 资助金额:
$ 11.92万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.92万 - 项目类别:
Research Grant














{{item.name}}会员




